Elemer Piros

Managing Director, Senior Equity Research Analyst

Dr. Piros joins Burrill from Rodman & Renshaw, where he served as a Managing Director and Senior Biotechnology Analyst since 2002. He has ranked among the top analysts in various surveys, including ranking as the top biotechnology analyst by The Wall Street Journal in 2006 and by the Financial Times in 2010 based on stock portfolio performance. Prior to that, he served as a senior biotechnology analyst at Ladenburg Thalmann, and a biotechnology research analyst with Spear, Leeds & Kellogg/Goldman Sachs.

Before serving as an analyst, Piros spent eight years conducting research in biophysics, biochemistry, and molecular biology at Cornell University and the University of California, Los Angeles. He holds a Ph.D. in Neurosciences from UCLA, a B.S. in biology from UCLA, and a B.S. in mathematics and technology from Eotvos Lorand University in Budapest